Lincoln Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 821.153 million compared to INR 826.542 million a year ago. Net income was INR 125.73 million compared to INR 89.443 million a year ago. Basic earnings per share from continuing operations was INR 6.29 compared to INR 4.47 a year ago. For the full year, total revenue was INR 4,298.493 million compared to INR 3,975.307 million a year ago. Net income was INR 622.241 million compared to INR 514.392 million a year ago. Basic earnings per share from continuing operations was INR 31.11 compared to INR 25.72 a year ago.